These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21514150)

  • 21. Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
    Crosignani S; Page P; Missotten M; Colovray V; Cleva C; Arrighi JF; Atherall J; Macritchie J; Martin T; Humbert Y; Gaudet M; Pupowicz D; Maio M; Pittet PA; Golzio L; Giachetti C; Rocha C; Bernardinelli G; Filinchuk Y; Scheer A; Schwarz MK; Chollet A
    J Med Chem; 2008 Apr; 51(7):2227-43. PubMed ID: 18318469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists.
    Yang C; Shen HC; Wu Z; Chu HD; Cox JM; Balsells J; Crespo A; Brown P; Zamlynny B; Wiltsie J; Clemas J; Gibson J; Contino L; Lisnock J; Zhou G; Garcia-Calvo M; Bateman T; Xu L; Tong X; Crook M; Sinclair P
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4388-92. PubMed ID: 23777778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates.
    Sanderson PE; Lyle TA; Cutrona KJ; Dyer DL; Dorsey BD; McDonough CM; Naylor-Olsen AM; Chen IW; Chen Z; Cook JJ; Cooper CM; Gardell SJ; Hare TR; Krueger JA; Lewis SD; Lin JH; Lucas BJ; Lyle EA; Lynch JJ; Stranieri MT; Vastag K; Yan Y; Shafer JA; Vacca JP
    J Med Chem; 1998 Nov; 41(23):4466-74. PubMed ID: 9804686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists.
    Perner RJ; Koenig JR; Didomenico S; Gomtsyan A; Schmidt RG; Lee CH; Hsu MC; McDonald HA; Gauvin DM; Joshi S; Turner TM; Reilly RM; Kym PR; Kort ME
    Bioorg Med Chem; 2010 Jul; 18(13):4821-9. PubMed ID: 20570528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
    Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
    Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
    J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.
    Murugesan N; Gu Z; Spergel S; Young M; Chen P; Mathur A; Leith L; Hermsmeier M; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Koplowitz B; Humphreys WG; Chong S; Morrison RA; Webb ML; Moreland S; Trippodo N; Barrish JC
    J Med Chem; 2003 Jan; 46(1):125-37. PubMed ID: 12502366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of diphenyloxazole and Ndelta-Z-ornithine derivatives as highly potent and selective human prostaglandin EP(4) receptor antagonists.
    Hattori K; Tanaka A; Fujii N; Takasugi H; Tenda Y; Tomita M; Nakazato S; Nakano K; Kato Y; Kono Y; Murai H; Sakane K
    J Med Chem; 2005 May; 48(9):3103-6. PubMed ID: 15857112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists.
    Chen YL; Braselton J; Forman J; Gallaschun RJ; Mansbach R; Schmidt AW; Seeger TF; Sprouse JS; Tingley FD; Winston E; Schulz DW
    J Med Chem; 2008 Mar; 51(5):1377-84. PubMed ID: 18260619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
    Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.
    Epple R; Cow C; Xie Y; Azimioara M; Russo R; Wang X; Wityak J; Karanewsky DS; Tuntland T; Nguyêñ-Trân VT; Cuc Ngo C; Huang D; Saez E; Spalding T; Gerken A; Iskandar M; Seidel HM; Tian SS
    J Med Chem; 2010 Jan; 53(1):77-105. PubMed ID: 19928766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hit-to-Lead studies: the discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists.
    Baxter A; Cooper A; Kinchin E; Moakes K; Unitt J; Wallace A
    Bioorg Med Chem Lett; 2006 Feb; 16(4):960-3. PubMed ID: 16297626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
    Borthwick AD; Davies DE; Exall AM; Livermore DG; Sollis SL; Nerozzi F; Allen MJ; Perren M; Shabbir SS; Woollard PM; Wyatt PG
    J Med Chem; 2005 Nov; 48(22):6956-69. PubMed ID: 16250654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
    Winn M; von Geldern TW; Opgenorth TJ; Jae HS; Tasker AS; Boyd SA; Kester JA; Mantei RA; Bal R; Sorensen BK; Wu-Wong JR; Chiou WJ; Dixon DB; Novosad EI; Hernandez L; Marsh KC
    J Med Chem; 1996 Mar; 39(5):1039-48. PubMed ID: 8676339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
    O'Donnell CJ; Rogers BN; Bronk BS; Bryce DK; Coe JW; Cook KK; Duplantier AJ; Evrard E; Hajós M; Hoffmann WE; Hurst RS; Maklad N; Mather RJ; McLean S; Nedza FM; O'Neill BT; Peng L; Qian W; Rottas MM; Sands SB; Schmidt AW; Shrikhande AV; Spracklin DK; Wong DF; Zhang A; Zhang L
    J Med Chem; 2010 Feb; 53(3):1222-37. PubMed ID: 20043678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel and potent CRTH2 antagonists.
    Ito S; Terasaka T; Zenkoh T; Matsuda H; Hayashida H; Nagata H; Imamura Y; Kobayashi M; Takeuchi M; Ohta M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1194-7. PubMed ID: 22178554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists.
    Asada M; Obitsu T; Kinoshita A; Nakai Y; Nagase T; Sugimoto I; Tanaka M; Takizawa H; Yoshikawa K; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2639-43. PubMed ID: 20346663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent.
    Odan M; Ishizuka N; Hiramatsu Y; Inagaki M; Hashizume H; Fujii Y; Mitsumori S; Morioka Y; Soga M; Deguchi M; Yasui K; Arimura A
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2803-6. PubMed ID: 22444677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
    J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.